Financials

News Discussions Technicals Seasonals

CLBIO fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Corline Biomedical AB engages in the business of developing a portfolio of drug candidates for use in connection with organ and cell transplantation. The firm is also involved in developing, manufacturing, and marketing heparin-based solutions to improve kidney transplantation, cell therapies, and applications in the evolving field of regenerative medicine. The company was founded in 1991 and is headquartered in Uppsala, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

CLBIO has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company